{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreic4kudrtr4e36yijeapsky4aj62vl75j2iluihwoxvpiqybyopsdm",
    "uri": "at://did:plc:2gbt2dlwaqovtnmxkat3tyke/app.bsky.feed.post/3mfdnmg4a7qe2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreieeacee5vhi7xjykqakt2moyhc5pmsmt3k2lj2te2tan5lkndnbkm"
    },
    "mimeType": "image/jpeg",
    "size": 280032
  },
  "path": "/articles/d41586-026-00552-6",
  "publishedAt": "2026-02-21T03:11:27.703Z",
  "site": "https://www.nature.com",
  "tags": [
    "doi:10.1038/d41586-026-00552-6"
  ],
  "textContent": "Nature, Published online: 20 February 2026; doi:10.1038/d41586-026-00552-6\n\nThe United Kingdom and Brazil have issued warnings about a possible link between GLP-1 weight-loss drugs and pancreatic inflammation, but the connection is murky.",
  "title": "Are obesity drugs causing a severe complication? What the science says",
  "updatedAt": "2026-02-20T00:00:00.000Z"
}